Urine cytology in bladder tumors

Area of Science:

• Urology
• Oncology
• Cytopathology

Background:

• Bladder cancer, particularly transitional cell carcinoma (TCC), necessitates accurate diagnostic and follow-up methods.
• Urine cytology is a non-invasive technique that can detect malignant cells shed from the urothelium.
• Evaluating the efficacy of urine cytology in a clinical setting is crucial for patient management.

Purpose of the Study:

• To review the experience with urine cytology for diagnosing and monitoring bladder cancer.
• To assess the correlation between urine cytology results and tumor characteristics such as grade and stage.
• To determine the diagnostic accuracy of urine cytology in patients with biopsy-proven TCC.

Main Methods:

• Retrospective review of patients with biopsy-proven TCC from 1971 to 1981.
• Analysis of 2,877 cytological evaluations from 677 patients.
• Detailed examination of 1,091 evaluations in a subgroup of 317 patients with concomitant cystoscopy, cytology, and biopsy.

Main Results:

• Overall positive cytology rate was 74.4% in patients with biopsy-proven bladder tumors.
• A linear correlation was observed between tumor grade/stage and positive cytology rates.
• High-grade tumors (89.9%) and carcinoma-in-situ (96.9%) showed higher positive cytology rates than Grade II tumors (64%).
• Positive cytology incidence increased with tumor invasion depth: 62% for submucosal involvement and 80% for muscle invasion.

Conclusions:

• Urine cytology is a valuable tool in the diagnosis and follow-up of bladder cancer.
• Cytology's sensitivity is significantly influenced by tumor grade and pathological stage.
• The findings support the utility of urine cytology in detecting and assessing the extent of transitional cell carcinoma.